Experian plc (EXPGY)
| Previous close | 41.25 |
| Open | 40.29 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 40.29 - 41.50 |
| 52-week range | 28.80 - 44.61 |
| Volume | |
| Avg. volume | 62,895 |
| Market cap | 37.856B |
| Beta (5Y monthly) | 0.64 |
| PE ratio (TTM) | 37.05 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.56 (1.35%) |
| Ex-dividend date | 04 Jan 2024 |
| 1y target est | N/A |
- Business Wire
Access to Healthcare and Digital Tools Turning a Corner for the Better, According to Providers and Patients
COSTA MESA, Calif., May 06, 2024--Healthcare providers and patients are in rare agreement that healthcare access and service-levels are improving, according to the Experian Health 2024 State of Patient Access survey. Almost a third (28%) of patients and 55 percent of providers surveyed say the environment is getting better while patients still say the top challenge is seeing a practitioner quickly.
- Business Wire
Survey Says: Personal Finance Knowledge Gaps Are Leading to Costly Mistakes
COSTA MESA, Calif., April 17, 2024--Lack of financial knowledge is leading to costly financial missteps for many Americans according to new research released today by Experian®.
- Business Wire
Experian Named a Leader in IDC MarketScape: Worldwide Enterprise Fraud Solutions 2024 Vendor Assessment
COSTA MESA, Calif., April 16, 2024--Experian announced that the company was named a Leader in the IDC MarketScape: Worldwide Enterprise Fraud Solutions 2024 Vendor Assessment (doc #US51939124, March 2024). The report evaluates each vendor’s advanced fraud detection capabilities, alignment with customer needs, and future strategy and roadmap for innovation.
